| 91 |
Technetium-99m pentavalent dimercaptosuccinic acid (99mTc-DMSA-V) brain SPECT/CT and Karnofsky performance score predict survival in patients with glioma
|
2017 |
| 92 |
Technetium-99m pentavalent dimercaptosuccinic acid (99mTc-DMSA-V) brain SPECT/CT and Karnofsky performance score predict survival in patients with glioma |
2017 |
| 93 |
Technetium-99m pentavalent dimercaptosuccinic acid (99mTc-DMSA-V) brain SPECT/CT and Karnofsky performance score predict survival in patients with glioma |
2017 |
| 94 |
The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis |
2017 |
| 95 |
The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis |
2017 |
| 96 |
The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis |
2017 |
| 97 |
The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis |
2017 |
| 98 |
The Prognostic Impact of Neutrophil Lymphocytic Ratio (NLR)
o n
Survival of Patients with Glioblastoma Multiforme (GBM): A
Retrospective Cohort Study |
2017 |
| 99 |
The Prognostic Impact of Neutrophil Lymphocytic Ratio (NLR)
o n
Survival of Patients with Glioblastoma Multiforme (GBM): A
Retrospective Cohort Study |
2017 |
| 100 |
Diagnostic Utility of 18F-FDG PECT/CT in Assesment of Post-therapy Remission or Relapse of Lymphoma |
2016 |
هل لديك سؤال ؟
